These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10170231)

  • 41. Reflections on the 20th anniversary of Taiwan's single-payer National Health Insurance System.
    Cheng TM
    Health Aff (Millwood); 2015 Mar; 34(3):502-10. PubMed ID: 25732502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The medical technology industry: a competence centre for health.
    Schmitt JM; Beeres M
    Med Device Technol; 2006 Apr; 17(3):52-3. PubMed ID: 16736668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One hundred and eighteen years of the German health insurance system: are there any lessons for middle- and low-income countries?
    Bärnighausen T; Sauerborn R
    Soc Sci Med; 2002 May; 54(10):1559-87. PubMed ID: 12061488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Introducing competition principles into health care through EU law and policy: a case study of the Netherlands.
    van de Gronden J; Szyszczak E
    Med Law Rev; 2014; 22(2):238-54. PubMed ID: 24841529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Competition and "cream skimming" in Germany: incentives and opportunities.
    Wysong JA; Abel T
    Soz Praventivmed; 1998; 43(1):5-6. PubMed ID: 9544464
    [No Abstract]   [Full Text] [Related]  

  • 46. The Canadian health care system as a managed care model for the United States.
    Chernomas R; Sepehri A
    Health Care Manag; 1995 Oct; 2(1):183-90. PubMed ID: 10165632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
    Götze R
    Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
    [No Abstract]   [Full Text] [Related]  

  • 48. Risk equalization, competition and choice in Germany: a reply to Wysong and Abel.
    Winkelhake O; John J
    Soz Praventivmed; 1998; 43(1):3-4. PubMed ID: 9544463
    [No Abstract]   [Full Text] [Related]  

  • 49. State health services commissions German style.
    Weil TP
    Hosp Top; 1995; 73(4):29-35. PubMed ID: 10154280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of cost and utilization of pharmaceuticals in Germany.
    von der Schulenburg JM
    Health Policy; 1997 Sep; 41 Suppl():S45-53. PubMed ID: 10174473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is single-payer national health insurance the answer?
    Pearson LJ
    Nurse Pract; 2004 Jan; 29(1):7. PubMed ID: 14726781
    [No Abstract]   [Full Text] [Related]  

  • 53. Forming and reforming the market for third-party purchasing of health care: a German perspective.
    Graf von der Schulenburg JM
    Soc Sci Med; 1994 Nov; 39(10):1473-81. PubMed ID: 7863359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Economics and ethics in public health?].
    Blum R
    Gesundheitswesen; 1999 Jan; 61(1):1-7. PubMed ID: 10081179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of order and complements: a new way to understand the Dutch and German health insurance reforms.
    Helderman JK; Stiller S
    J Health Polit Policy Law; 2014 Aug; 39(4):811-40. PubMed ID: 24842966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Agency and incentives in the NHS internal market.
    Propper C
    Soc Sci Med; 1995 Jun; 40(12):1683-90. PubMed ID: 7660181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reforming health care in The Netherlands.
    te Maarssen AM; Janssen R
    Health Serv Manage; 1994 Jan; 90(1):19-21. PubMed ID: 10134206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.
    Fronstin P; Ross MN
    EBRI Issue Brief; 2009 Jun; (330):1-22. PubMed ID: 19545086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health care reform in Germany: patchwork change within established governance structures.
    Altenstetter C; Busse R
    J Health Polit Policy Law; 2005; 30(1-2):121-42. PubMed ID: 15943390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Insured patients will not notice initially--revisions of Spibu (Association of Public Health Insurance)].
    Schulte-Wissermann H
    Kinderkrankenschwester; 2008 Aug; 27(8):314. PubMed ID: 18757029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.